NCT05791578|Unknown
Relationship Obsessive Beliefs and Thought Control
Corresponding Author
Loading search results
Corresponding Author
Sponsor study identifier
observational
1
1 country
1
Study Start
December 1, 2022
Actual (reported)Primary Completion
May 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 20, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Obsessive beliefs and thought control have been mostly investigated in obsessive-compulsive disorder in the literature. However, there is an increasing body of literature indicating that obsessive beliefs and thought control also play a role in the development of other anxiety disorders. In the study, investigators hypothesised that obsessive beliefs and thought control are effective in generalised anxiety disorder and panic disorder and increase anxiety symptoms and aimed to investigate the accuracy of this hypothesis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 20, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 1, 2022
Actual (reported)January 30, 2023
Actual (reported)March 30, 2023
Actual (reported)May 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 20, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The study will include healthy controls, patients with panic disorder and patients with anxiety disorder. 3 groups will be formed and obsessive beliefs scale and thought control scale will be applied to the groups.
Obsessive beliefs and will be applied in patients with panic disorder and anxiety disorder. scale results will be evaluated statistically. the hypothesis of the study is that obsessive beliefs scale scores will be higher in the patient group. The mentioned scales are the scales used for diagnosis in psychiatry. the answers have a score and a numerical value is obtained by adding the scores. the lowest score that can be obtained from the obsessive beliefs scale is 44 and the highest score is 208. higher scores on the scale are negative and mean more obsessive beliefs
3 months
The study will include healthy controls, patients with panic disorder and patients with anxiety disorder. 3 groups will be formed and obsessive beliefs scale and thought control scale will be applied to the groups.
thought control scale will be applied in patients with panic disorder and anxiety disorder. scale results will be evaluated statistically. the hypothesis of the study is that thought control scale scores will be higher in the patient group. The mentioned scales are the scales used for diagnosis in psychiatry. the answers have a score and a numerical value is obtained by adding the scores.. the lowest score that can be obtained from the thought control scale is 30 and the highest is 120. increasing scores were evaluated negatively. it is associated with more difficult thought control.
3 months
with panic disorder patient and generalized anxiety disorder patient
RTE University
Rize, 53200, Turkey (Türkiye)
First Submitted
January 30, 2023
First Posted
March 30, 2023
Study Start
December 1, 2022
Actual (reported)Primary Completion
May 1, 2023
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 20, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 30, 2023
Record last verified: 2023-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: